Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus PneumoniaZhang, Shengyu ; Li, Lei ; Shen, Aizong ; Chen, Yongwu ; Qi, ZhigangClinical drug investigation, 2020-06, Vol.40 (6), p.511-518 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
2 |
Material Type: Artigo
|
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-ReviewPlantone, Domenico ; Koudriavtseva, TatianaClinical drug investigation, 2018-08, Vol.38 (8), p.653-671 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
3 |
Material Type: Artigo
|
Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature ReviewKarsten Dafonte, Katharina ; Weber, Lisa ; Chmielewski, Florian ; Böhmer, Anna Maria ; Lutz, Philipp ; Hartmann, Gunther ; Jaehde, Ulrich ; Coenen, MartinClinical drug investigation, 2023-07, Vol.43 (7), p.475-502 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
4 |
Material Type: Artigo
|
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study FindingsKoshimichi, Hiroki ; Ishibashi, Toru ; Kawaguchi, Nao ; Sato, Chisako ; Kawasaki, Akira ; Wajima, ToshihiroClinical drug investigation, 2018-12, Vol.38 (12), p.1189-1196 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
5 |
Material Type: Artigo
|
Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERSJi, Huan-huan ; Tang, Xue-wen ; Dong, Zhi ; Song, Lin ; Jia, Yun-taoClinical drug investigation, 2019-03, Vol.39 (3), p.319-330 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
6 |
Material Type: Artigo
|
Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in GreeceGourzoulidis, George ; Solakidi, Argyro ; Psarra, Marina ; Nikitopoulou, Eleni ; Tzanetakos, CharalamposClinical drug investigation, 2024, Vol.44 (1), p.59-69 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
7 |
Material Type: Artigo
|
Optimising Decision Making in Chronic Venous Disease Management with Micronised Purified Flavonoid FractionUlloa, Jorge H.Clinical drug investigation, 2023-06, Vol.43 (Suppl 1), p.15-19 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
8 |
Material Type: Artigo
|
The Safety of Melatonin in HumansAndersen, Lars Peter Holst ; Gögenur, Ismail ; Rosenberg, Jacob ; Reiter, Russel J.Clinical drug investigation, 2016-03, Vol.36 (3), p.169-175 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
9 |
Material Type: Artigo
|
Correction to: Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in JapanIshibashi, Yukiko ; Sogawa, Rintaro ; Ogata, Kenji ; Matsuoka, Ayaka ; Yamada, Haruna ; Murakawa-Hirachi, Toru ; Mizoguchi, Yoshito ; Monji, Akira ; Shimanoe, ChisatoClinical drug investigation, 2024-02, Vol.44 (2), p.121-121 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
10 |
Material Type: Artigo
|
Correction: Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese SubjectsShen, Qi ; Jin, Ying ; Di, Xiangjie ; Hu, Chao ; Liu, Runhan ; Wang, Ying ; Qi, Xiaohui ; Wang, Yongsheng ; Wang, ZhenleiClinical drug investigation, 2023-12, Vol.43 (12), p.973-974 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |